Funding round
Isomorphic Labs Series B
Isomorphic Labs, which works in AI-Driven drug discovery services in London, raised $2.10B in a Series B round announced on 12 May 2026, led by Thrive Capital. 7 firms took part, 3 of them already investors. It is Isomorphic Labs' second venture round on record; the one before was a Growth in Mar 2025.
$2.10B
Amount raised
Not disclosed
Post-money valuation
7
Investors
1 lead
Valuation
What this round says about the price
Isomorphic Labs did not disclose a valuation in this round. It came 14 months after Isomorphic Labs' Growth. It is 78% of the $2.70B Isomorphic Labs has raised in the venture rounds on record. No later venture round is on record for Isomorphic Labs.
Isomorphic Labs' funding rounds
Isomorphic Labs has 2 venture rounds on record. This one is highlighted.
- Growth 31 Mar 2025, led by Thrive Capital $600M
- Series B this round 12 May 2026, led by Thrive Capital $2.10B
Investors
Who put money in
Thrive Capital led the round with 6 other firms. Thrive Capital, Alphabet and GV had backed Isomorphic Labs before.
Lead investor
- Thrive Capital backs 130 venture-backed companies existing investor
Use of proceeds
What the money is for
According to the announcement, the money goes to hiring, product development, geographic expansion, scaling operations and working capital.
- Hiring
- Product development
- Geographic expansion
- Scaling operations
- Working capital
Comparable rounds
How it compares
76 Series B rounds in Biotechnology within a year either side disclosed an amount; the median was $60M, and this round was 35 times the median. The closest in time, other companies' Series B rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Biotechnology | 14 May 2026 | $122M | not disclosed | Newpath Partners and ARCH Venture Partners |
| Biotechnology | 1 May 2026 | $20M | not disclosed | not named |
| Biotechnology | 8 Apr 2026 | $137M | not disclosed | Frazier Life Sciences and Novartis Venture Fund |
| Biotechnology | 21 Apr 2026 | $125M | not disclosed | Janus Henderson Investors |
| Biotechnology | 13 Apr 2026 | $100M | not disclosed | Deerfield |
| Biotechnology | 4 Jun 2026 | $87M | not disclosed | Columbus Venture Partners and Mérieux Equity Partners |
| Biotechnology | 22 Jun 2026 | $74M | not disclosed | The Column Group |
| Biotechnology | 16 Jun 2026 | $27M | not disclosed | not named |
Sources
Where this comes from
Reported by 4 sources.
Questions
Frequently asked
How much did Isomorphic Labs raise in its Series B round?
Isomorphic Labs raised $2.10B in its Series B round, announced in May 2026.
Who led Isomorphic Labs' Series B round?
Thrive Capital led it, with Alphabet, GV, MGX, Temasek and CapitalG and 1 more.
What was Isomorphic Labs' valuation at the Series B round?
It was not disclosed.
How does it compare with other Series B rounds in Biotechnology?
76 Series B rounds in Biotechnology within a year either side disclosed an amount; the median was $60M, and this round was 35 times the median.